Clinical Trial Update: Preventing Tolerance to Oxymetazoline in Allergic Rhinitis [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating prevention of tolerance (tachyphylaxis) to oxymetazoline nasal decongestant in allergic rhinitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Rhinitis Medicamentosa

Drugs mentioned

• Oxymetazoline (oxymetazoline)

Snippet

Sponsor: Brian J Lipworth | Conditions: Allergic Rhinitis, Tachyphylaxis | Phase 4 | Status: WITHDRAWN